Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial

Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer

ASCO 2015: Latest in chronic lymphocytic leukaemia

Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma

Subgroup analysis of molecular markers in phase III study of high risk low-grade glioma

Initial nivolumab-based treatment halts melanoma progression

Comment: Eribulin extends overall survival for advanced liposarcoma and leiomyosarcoma

New intelligence network that supports efforts to improve quality of care and development of new medicines

Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs

Advanced DNA sequencing test used to match rare cancers

Developments in clinical trials and health information technology that will improve targeted therapies for patients

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL